Korro Bio, Inc. financial data

Symbol
KRRO on Nasdaq
Location
Cambridge, MA
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 12 Mar 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 714% % -37%
Return On Equity -116% % -139%
Return On Assets -71% % -96%
Operating Margin -1906% % 53%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 14,422,571 shares 54%
Common Stock, Shares, Outstanding 9,417,295 shares 0.43%
Entity Public Float $88,968,431 USD -62%
Common Stock, Value, Issued $9,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 9,395,402 shares 5.3%
Weighted Average Number of Shares Outstanding, Diluted 9,395,402 shares 5.3%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $6,392,000 USD 181%
Research and Development Expense $65,575,000 USD 3%
General and Administrative Expense $28,159,000 USD -7.8%
Operating Income (Loss) $121,855,000 USD -33%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $116,623,000 USD -40%
Income Tax Expense (Benefit) $637,000 USD 352%
Net Income (Loss) Attributable to Parent $117,260,000 USD -40%
Earnings Per Share, Basic -12.48 USD/shares -33%
Earnings Per Share, Diluted -12.48 USD/shares -33%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $21,824,000 USD -61%
Marketable Securities, Current $53,332,000 USD -24%
Assets, Current $82,372,000 USD -37%
Property, Plant and Equipment, Net $8,164,000 USD -71%
Operating Lease, Right-of-Use Asset $8,058,000 USD -66%
Other Assets, Noncurrent $2,472,000 USD -12%
Assets $113,506,000 USD -50%
Accounts Payable, Current $1,651,000 USD -59%
Accrued Liabilities, Current $7,614,000 USD 23%
Liabilities, Current $11,937,000 USD -20%
Operating Lease, Liability, Noncurrent $40,814,000 USD -6.1%
Other Liabilities, Noncurrent $1,481,000 USD 0.61%
Liabilities $62,067,000 USD -5.7%
Accumulated Other Comprehensive Income (Loss), Net of Tax $212,000 USD -21%
Retained Earnings (Accumulated Deficit) $383,846,000 USD -44%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $51,439,000 USD -68%
Liabilities and Equity $113,506,000 USD -50%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $24,452,000 USD -12%
Net Cash Provided by (Used in) Financing Activities $172,000 USD 24%
Net Cash Provided by (Used in) Investing Activities $32,781,000 USD
Common Stock, Shares Authorized 200,000,000 shares 0%
Common Stock, Shares, Issued 9,417,295 shares 0.43%
Common Stock, Par or Stated Value Per Share 0.001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $8,501,000 USD
Deferred Tax Assets, Valuation Allowance $202,344,000 USD 20%
Deferred Tax Assets, Gross $204,546,000 USD 14%
Operating Lease, Liability $43,486,000 USD -2.9%
Depreciation $4,280,000 USD 20%
Payments to Acquire Property, Plant, and Equipment $119,000 USD -98%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $117,316,000 USD -41%
Lessee, Operating Lease, Liability, to be Paid $67,396,000 USD -8.4%
Property, Plant and Equipment, Gross $18,733,000 USD -47%
Operating Lease, Liability, Current $2,672,000 USD 108%
Lessee, Operating Lease, Liability, to be Paid, Year Two $7,557,000 USD 2.9%
Lessee, Operating Lease, Liability, to be Paid, Year One $7,341,000 USD 18%
Operating Lease, Weighted Average Discount Rate, Percent 0.112 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $23,910,000 USD -17%
Lessee, Operating Lease, Liability, to be Paid, Year Three $7,778,000 USD 2.9%
Deferred Tax Assets, Operating Loss Carryforwards $124,617,000 USD 32%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Unrecognized Tax Benefits $0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four $8,007,000 USD 2.9%
Additional Paid in Capital $435,064,000 USD 2%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance $2,202,000 USD -79%
Share-based Payment Arrangement, Expense $7,655,000 USD 72%
Preferred Stock, Par or Stated Value Per Share 0.001 USD/shares 0%